Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
515(7527):443-7
the regulatory CK2β subunit
CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)/C=C/CN2CCCCC2)N(C1=O)S(C)(=O)=O
NVP-ADW742 was found to suppresse survival and resistance to chemotherapy in acute myeloid leukemia cells
70(2):1017-22
CB-839 H 298 515(7527):443-7Telaglenastat, also known as CB 839, an is orally bioavailable inhibitor of glutaminase, with potential antineoplastic activity. Telaglenastat selectively and irreversibly inhibits glutaminase. By blocking glutamine utilization, proliferation in rapidly growing cells is impaired. Glutamine dependent tumors rely on the conversion of exogenous glutamine into glutamate and glutamate metabolites to both provide energy and generate building blocks for the
US$ 129.00
US$ 129.00
US$ 150.00
US$ 139.00
US$ 120.00
US$ 11.99
US$ 139.00
US$ 15.00
US$ 129.00
US$ 129.00
US$ 129.00
US$ 129.00
US$ 55.00
US$ 150.00
US$ 150.00
US$ 129.00